In this episode, we speak with Dr. Tom Kelly, CEO and founder of Heidi, about the platform's evolution from a free AI scribe into a multi-product clinical AI suite now supporting nearly 2.5 million visits per week across 116 countries. Tom explains how Heidi's two newest products, Evidence and Comms, give clinicians agentic tools to query medical literature, conduct surgical audits, and engage patients across phone, text, and web with full visit context. We discuss why scribing reliability is harder than it looks, how Heidi is navigating medical device regulation in the UK and EU through their Automedica acquisition, and why Tom believes the future of clinical AI is a single platform, not a collection of disconnected point solutions.